Correction

A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency (Jan, 10.1007/s10875-021-01181-6, 2022)

Journal

JOURNAL OF CLINICAL IMMUNOLOGY
Volume 42, Issue 3, Pages 512-513

Publisher

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10875-022-01219-3

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Recommended

No Data Available
No Data Available